These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27141989)

  • 1. A Computational Analysis of Indomethacin Derivative as Tubulin Inhibitor: Insights into Development of Chemotherapeutic Agents.
    Costa KM; Alves CN; Silva JR; Lameira J
    Comb Chem High Throughput Screen; 2016; 19(6):431-6. PubMed ID: 27141989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization.
    Ma Y; Fang S; Li H; Han C; Lu Y; Zhao Y; Liu Y; Zhao C
    Chem Biol Drug Des; 2013 Jul; 82(1):12-21. PubMed ID: 23786349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
    Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
    Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design.
    Cheng J; Wu Y; Wang Y; Wang C; Wang Y; Wu C; Zeng S; Yu Y; Chen Q
    Biochem Biophys Res Commun; 2018 Jan; 495(1):185-188. PubMed ID: 29102632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
    Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
    Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Hadizadeh F; Ghodsi R; Mirzaei S; Sahebkar A
    Comput Math Methods Med; 2022; 2022():4004068. PubMed ID: 35075369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel 5-(4-chlorophenyl)furan derivatives with inhibitory activity on tubulin polymerization.
    Moussa SA; A Osman EE; Eid NM; Abou-Seri SM; El Moghazy SM
    Future Med Chem; 2018 Aug; 10(16):1907-1924. PubMed ID: 29966433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into the design of indole derivatives as tubulin polymerization inhibitors.
    Li Y; Yang J; Niu L; Hu D; Li H; Chen L; Yu Y; Chen Q
    FEBS Lett; 2020 Jan; 594(1):199-204. PubMed ID: 31369682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ligands of the tubulin colchicine site based on X-ray structures.
    Álvarez R; Medarde M; Peláez R
    Curr Top Med Chem; 2014; 14(20):2231-52. PubMed ID: 25434358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Biological Evaluation of Chalcone-Containing Shikonin Derivatives as Inhibitors of Tubulin Polymerization.
    Qiu HY; Wang F; Wang X; Sun WX; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH
    ChemMedChem; 2017 Mar; 12(5):399-406. PubMed ID: 28211616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
    Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of 4'-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design.
    Niu L; Wang Y; Wang C; Wang Y; Jiang X; Ma L; Wu C; Yu Y; Chen Q
    Biochem Biophys Res Commun; 2017 Nov; 493(1):718-722. PubMed ID: 28864414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1,2,4-triazole-3-thione/thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity.
    Ameri A; Khodarahmi G; Hassanzadeh F; Forootanfar H; Hakimelahi GH
    Arch Pharm (Weinheim); 2016 Aug; 349(8):662-81. PubMed ID: 27320785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity.
    Tripathi A; Durrant D; Lee RM; Baruchello R; Romagnoli R; Simoni D; Kellogg GE
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1237-44. PubMed ID: 19912057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors.
    Olazarán FE; García-Pérez CA; Bandyopadhyay D; Balderas-Rentería I; Reyes-Figueroa AD; Henschke L; Rivera G
    J Mol Model; 2017 Mar; 23(3):85. PubMed ID: 28214932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel class of tubulin inhibitors with promising anticancer activities.
    Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
    Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.